Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/17/1992 | WO1992015558A1 Indian derivative and thromboxane antagonist containing the same |
09/17/1992 | WO1992015551A1 Aliphatic propargylamines as selective mao-b inhibitors and as neuroprotective agents |
09/17/1992 | WO1992015319A1 Hiv protease inhibitors |
09/17/1992 | WO1992015315A1 Method for the treatment of herpes |
09/17/1992 | WO1992015313A1 Lowering blood cholesterol levels using cellulose ethers |
09/17/1992 | WO1992015312A1 Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers |
09/17/1992 | WO1992015309A1 Antiviral nucleoside combination |
09/17/1992 | WO1992015308A1 Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b |
09/17/1992 | WO1992015307A1 6,9-BIS(AMINO SUBSTITUTED)BENZO[g]PHTHALAZINE-5,10-DIONES AS ANTITUMOR AGENTS |
09/17/1992 | WO1992015306A1 Use of nicotinic analogs for treatment of degenerative diseases of the nervous system |
09/17/1992 | WO1992015305A1 Method of treatment for asthma, bronchospasm and obstructive lung disease |
09/17/1992 | WO1992015301A1 Treatment of hypertension and peripheral vascular diseases |
09/17/1992 | WO1992015300A1 6,9 BIS(SUBSTITUTED-AMINO)BENZO[g]ISOQUINOLINE-5,10-DIONES |
09/17/1992 | WO1992015299A1 Topical treatment of acne |
09/17/1992 | WO1992015298A2 Pyrazole derivatives for treatment of gastrointestinal ulcer disease |
09/17/1992 | WO1992015297A1 Agents, especially levamisole, against the human immunodeficiency virus |
09/17/1992 | WO1992015294A1 Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
09/17/1992 | WO1992015292A1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
09/17/1992 | WO1992015291A1 Pharmaceutical preparations for the therapy of tumors containing colchicine as the active principle and methods for the use of the same |
09/17/1992 | WO1992015290A1 Methods for treatment of scarring fibrotic alopecia |
09/17/1992 | WO1992012960A3 Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition |
09/17/1992 | WO1992010504A3 Phosphonic acid derivatives useful as antiinflammatory agents |
09/17/1992 | DE4207657A1 Medical adhesive containing di:sulphide pharmaceutical - comprises adhesive base of ABA block copolymer, sticky material, oil, hydrophilic polymer and water |
09/17/1992 | DE4108527A1 Neue 1-(4-cyano-4-aryl-cyclohexyl)piperazine, ihre herstellung und verwendung New 1- (4-cyano-4-aryl-cyclohexyl) piperazine, their preparation and use |
09/17/1992 | DE4108393A1 Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln New bi- and tricyclic ester amino alcohols, their production and their use in medicinal products |
09/17/1992 | DE4108351A1 Neue leukotrien-b(pfeil abwaerts)4(pfeil abwaerts)-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel New leukotriene b (Down Arrow) 4 (down arrow) derivatives, process for their production and their use as drug |
09/17/1992 | DE4108119A1 Verfahren zur herstellung von 4'-chlor-2-((3-(10,11-dihydro-5h-dibenz(b,f)azepin-5-yl)propyl) methylaminno) acetophenon und seiner salze, die stabilisierungseiner salze, hierbei erhaeltliche produkte und pharmmazeutische zubereitungen, die diese enthalten (B, f) azepin-5-yl) propyl) methylaminno (3- (10,11-dihydro-5H-dibenz () acetophenone and its salts, a stabilizing salt, in this case - Process for the preparation of 4'-chloro-2 available products and pharmmazeutische preparations containing these |
09/17/1992 | CA2439322A1 Therapeutic nucleosides |
09/17/1992 | CA2362719A1 Synthesis of nicotinic analogs useful for the treatment of degenerative diseases of the nervous system |
09/17/1992 | CA2105171A1 Aliphatic propargylamines as selective mao-b inhibitors and as neuroprotective agents |
09/17/1992 | CA2104951A1 Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
09/17/1992 | CA2104946A1 Imidazole-derivatives having agonistic or antagonistic activity on the histamine h3-receptor |
09/17/1992 | CA2104582A1 6,9 bis(substituted-amino)benzo [g]isoquinoline-5,10-diones |
09/17/1992 | CA2086259A1 Topical treatment of acne |
09/16/1992 | WO1992016528A1 New bi- and tricyclic aminoalcohol esters, their preparation and their use in medicaments |
09/16/1992 | WO1992016516A1 New 1-aryl-4-piperazinyl-cyclohexanecarboxylic acid nitriles, their production and their use |
09/16/1992 | WO1992016494A1 Long chain antiviral compounds |
09/16/1992 | WO1992016207A1 USE OF OXAZOLO-[2,3-a]ISOINDOLE AND IMIDAZO[2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO[2,3-a]ISOINDOLE DERIVATIVES |
09/16/1992 | EP0504055A1 Compositions comprising glucides for use in diet and therapy, and their uses |
09/16/1992 | EP0504017A1 Benzopyran derivatives, process for their preparation and pharmaceutical compositions containing them |
09/16/1992 | EP0503988A1 Compositions to treat onychomycoses |
09/16/1992 | EP0503949A1 Novel process for the preparation of 9-deoxo-9(z)-hydroxyiminoerythromycin A |
09/16/1992 | EP0503932A1 9-Deoxo-9(z)-hydroxy-iminoerythromycin A and O-derivatives thereof |
09/16/1992 | EP0503887A2 Promotion of wound-healing with 15-keto-prostaglandin compounds |
09/16/1992 | EP0503885A1 Avermectin compounds with a 6,5-spiroketal ring system |
09/16/1992 | EP0503852A1 Soap compounded with vitamin B1-containing garlic extract |
09/16/1992 | EP0503844A1 Thienopyridine derivatives and pharmaceutical compositions containing them |
09/16/1992 | EP0503838A2 Heterocyclic compounds bearing acidic functional groups as angiotensin II antagonists |
09/16/1992 | EP0503830A1 Trans-platinum compounds with anti-tumor activity, process for their preparation and compositions containing them |
09/16/1992 | EP0503785A1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use |
09/16/1992 | EP0503710A2 Flunarizine containing anti-neoplastic compositions |
09/16/1992 | EP0503627A1 Aminopyridine compounds |
09/16/1992 | EP0503604A2 Allenyl beta-lactam compounds and process for preparing same |
09/16/1992 | EP0503582A1 Glycyrrhetic acid derivatives |
09/16/1992 | EP0503563A2 Novel 8-substituted purines as selective adenosine receptor agents |
09/16/1992 | EP0503548A1 Cyclic urea derivatives, medicaments contaning them and process for their preparation |
09/16/1992 | EP0503538A1 Medicinal composition containing an anthelmintic cyclic depsipeptide |
09/16/1992 | EP0503537A1 6,9 Bis(substituted-amino)benzo-[g]isoquinoline-5,10-diones |
09/16/1992 | EP0503521A1 Low dose dry pharmaceutical preparations |
09/16/1992 | EP0503520A1 Cyclic ketal derivatives |
09/16/1992 | EP0503502A2 Sensor processor for high-speed mail-handling machine |
09/16/1992 | EP0503496A1 Lowering blood cholesterol levels using cellulose ethers |
09/16/1992 | EP0503484A2 Monoclonal antibodies as antidotes |
09/16/1992 | EP0503471A1 Acylaminosubstituted hetrazepines |
09/16/1992 | EP0503453A2 New process for the production of cephalosporines and novel intermediates in this process |
09/16/1992 | EP0503440A1 Compositions containing sumatriptan |
09/16/1992 | EP0503426A1 Quinone derivatives |
09/16/1992 | EP0503411A1 Substituted N-phenylpiperidines and medicaments thereof |
09/16/1992 | EP0503388A1 Pregna-21-oic acid esters |
09/16/1992 | EP0503349A1 Hydrazone derivatives, their preparation and use |
09/16/1992 | EP0503180A2 Improved antiperspirant formulations |
09/16/1992 | EP0503162A1 Azole derivatives, process for their preparation and their application |
09/16/1992 | EP0503035A1 NOVEL 1$g(a)-HYDROXY VITAMIN D 4? AND NOVEL INTERMEDIATES AND ANALOGUES |
09/16/1992 | EP0313630B1 Substituted 2-acylpyridin-alpha-(n)-hetarylhydrazones and medicaments containing same |
09/16/1992 | CN1064485A Imidazole, triazole and tetrazole derivatives |
09/16/1992 | CN1064482A Process for preparing 3-cycloalkyl-propanamides, their tautomer forms and their salts |
09/16/1992 | CN1064407A Pharmaceutical composition |
09/16/1992 | CA2108899A1 Use of oxazolo-[2,3-a]-isoindole and imidazo-[2,1-a]- isoindole derivatives as antiviral medicaments, as well as new oxazolo-[2,3-a]-isoindole derivatives |
09/16/1992 | CA2106068A1 Long chain antiviral compounds |
09/16/1992 | CA2099870A1 1-aryl-4-piperazinylcyclohexanecarbonitriles, the preparation and use thereof |
09/16/1992 | CA2063039A1 Use of phosphatidylserine and its derivatives in degenerative pathologies also associated with immune disfunctions |
09/16/1992 | CA2062932A1 9-deoxo-9(z)-hydroxyiminoerythromycin a and o-derivatives thereof |
09/16/1992 | CA2062853A1 Hydrazone derivatives, their preparation and use |
09/16/1992 | CA2062672A1 Aminopyridine compounds |
09/15/1992 | WO1992016508A1 Reissert compounds as anti-hiv agents |
09/15/1992 | WO1992016186A1 Cosmetic or pharmaceutical, especially dermatological, composition,containing oxyacanthine, in particular for stimulating hair growth or retarding hair loss |
09/15/1992 | US5147889 2-hydroxy-3-(aryl-alkanoyl)-benzo[B]thiophenes and compositions thereof |
09/15/1992 | US5147885 Glaucoma, anticoagulants |
09/15/1992 | US5147883 Acylbenzoxazolinones compounds |
09/15/1992 | US5147882 Cardiovascular disorders |
09/15/1992 | US5147881 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents |
09/15/1992 | US5147880 Estrogenic and antiestrogenic activity |
09/15/1992 | US5147879 O-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same |
09/15/1992 | US5147878 Hypotensive, antiarrhythmia agents |
09/15/1992 | US5147875 Bronchodilation |
09/15/1992 | US5147870 Antilepemic, anticholesterol agents |
09/15/1992 | US5147869 Salbutamol and trenbolone acetate, animal weight increase |
09/15/1992 | US5147868 Thienamycin renal peptidase inhibitors |
09/15/1992 | US5147867 Phosphorus containing enzyme inhibitors |
09/15/1992 | US5147866 Hypotensive, bronchodilator agents |